25.08.2013 Views

Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer

Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer

Sudbø-saken UiO 2006.pdf - De nasjonale forskningsetiske komiteer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

14: Sudbo J. [Chemoprevention of oral cancer] Tidsskr Nor Laegeforen. 2003 May<br />

29;123(11):1518-21. Review. Norwegian.<br />

15: Sudbo J. [Chemoprevention: treatment of persons at high risk of cancer] Tidsskr Nor<br />

Laegeforen. 2003 May 29;123(11):1514-7. Review. Norwegian.<br />

16: Sudbo J, Ristimaki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B,<br />

Nesland JM, Bryne M. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral<br />

lesions. Oral Oncol. 2003 Jul;39(5):497-505.<br />

17: Scully C, Sudbo J, Speight PM. Progress in determining the malignant potential of oral<br />

lesions. J Oral Pathol Med. 2003 May;32(5):251-6. Review.<br />

18: Sudbo J, Reith A. When is an oral leukoplakia premalignant?<br />

Oral Oncol. 2002 <strong>De</strong>c;38(8):813-4; author reply 811-2. No abstract available.<br />

19: Sudbo J, Reith A. Which putatively pre-malignant oral lesions become oral cancers? Clinical<br />

relevance of early targeting of high-risk individuals.<br />

J Oral Pathol Med. 2003 Feb;32(2):63-70. Review.<br />

20: Reith A, Sudbo J. Impact of genomic instability in risk assessment and chemoprevention of<br />

oral premalignancies. Int J Cancer. 2002 Sep 20;101(3):205-9. Review.<br />

21: Sudbo J. [Adverse effects of COX-2 inhibitors] Tidsskr Nor Laegeforen. 2002 Jan<br />

10;122(1):102-3. Norwegian.<br />

22: Sudbo J. [DNA ploidy analysis--a possibility for early identification of patient with risk of<br />

oral cancer] Lakartidningen. 2001 Nov 7;98(45):4980-4. Review. Norwegian.<br />

23: Sudbo J. Pathology in disgrace? J Pathol. 2002 Feb;196(2):244-5. No abstract available.<br />

24: Sudbo J, Kildal W, Johannessen AC, Koppang HS, Sudbo A, Danielsen HE, Risberg B,<br />

Reith A. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up<br />

study in oral erythroplakias. J Clin Oncol. 2002 Jan 15;20(2):456-62.<br />

25: Sudbo J, Warloe T, Aamdal S, Reith A, Bryne M. [Diagnosis and treatment of oral<br />

precancerous lesions] Tidsskr Nor Laegeforen. 2001 Oct 30;121(26):3066-71. Norwegian.<br />

26: Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A.<br />

Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white<br />

patches. Oral Oncol. 2001 Oct;37(7):558-65.<br />

27: Sudbo J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the<br />

head and neck. N Engl J Med. 2001 Aug 2;345(5):376-7.<br />

28: Sudbo J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of<br />

histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral<br />

dysplasia. J Pathol. 2001 Jul;194(3):303-10.<br />

29: Sudbo J, Reith A, Lingjaerde OC. Gene-_expression profiles in hereditary breast cancer. N<br />

Engl J Med. 2001 Jun 28;344(26):2029. No abstract available.<br />

124

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!